What to Expect with Options Medical Weight Loss We tailor every program to meet your unique goals
GLP-1 therapy is an investment that needs a strategy to protect it
In skeletally mature female rats, moderate energy restriction over 12 weeks had minimal negative effects on bone, but severe restriction significantly reduced bone mass and levels of IGF-1, leptin, and estradiol
In May 2023, Pfizer released the results of a Phase 2b clinical trial of the drug
Vrang N, Jelsing J, Simonsen L, Jensen AE, Thorup I, Soeborg H, and Knudsen LB
LONDON The release of GLP-1 weight management pills is expected to further alter the purchasing habits of US consumers, according to data and insights company GlobalData